About us
Global Expertise, Personal Touch
Eurofins bioskin at a glance
Your partner for dematological trials
Since its inception in 1992, bioskin has been recognized as a valuable partner for clinical trials in dermatological indications. Starting as a small Contract Research Organization (CRO) specialized in conducting early phase safety and efficacy trials, bioskin has grown into a full-service CRO offering global dermatologic consulting and regulatory services and all services for management of Phase I-IV drug trials and medical device studies. bioskin is headquartered in Hamburg, Germany.
As of August 1, 2021 bioskin has become part of the Eurofins network of companies. By joining the Eurofins network, we strengthen our position as a leading provider of clinical dermatological trials for pharmaceuticals and medical devices.
We are unique in our understanding and capabilities for both early and late phase development of dermatological and related products. A core expertise is interpretation of study results, integrating biophysical measurement methods to deliver objective data about skin function and structure to support traditional clinical endpoints. For global early and late phase studies Eurofins bioskin partners with selected, reliable partners throughout Europe, US, Latin America, Central & Eastern Europe and South Africa.
